Given the price action, it is likely that investors believe CATO's guidance is pessimistic - or maybe that it is a repeat of an annual forecast made prior to the fiscal year and not updated.
Micro, you are correct about net margin. However, from the earnings release, "operating margin was 3%, compared to 9% and 4%, respectively, in the same period of fiscal year 2013.".
I guess I was assuming that you thought operating margin would return to 4%, not something higher in deriving your eps.
I guess this is quibbling, but net margin is before taxes and interest, so 500 mil sales would not really equal $2.00 eps. Given that 1st quarter is more than half over, you would think eps range guidance wouldn't be so wide.
A small sale, but if anything, I would have considered it a negative. I use a site showing insider trading, but this didn't show up: I guess it only reflects Form 4's, not SC13D/A (change in shares by big holders).
I'm not sure I got my original point communicated. Last try. When many people are using orders for less than 100 shares, the bid/ask does not reflect them, so spread appears larger than it is. Even if an order starts out for 100 shares, if 1 share is filled, and that can happen with this stock, it drops out of the bid/ask. So perhaps if you are trying to buy, you might meet the ask, if you knew what it was!
Incidentally, on other stocks, no else seems upset, but I've seen traders able to undercut the ask by a small fraction of a cent and steal the order (ditto on buy). Broker explanations don't hold up, and SEC is not interested. Maybe my English is poor.
No, not to increase value, but to promote efficient buy/sell. Spreads are large because they don't reflect blocks under 100 shares. Even if a block starts at 100 shares, a partial transaction reduces the block and knocks its price out of the bid/ask spread.
My experience is that typically pre-release trading is not an indicator, but in this case it certainly is likely somebody had an idea of what was going on. I wonder if sellers of Dynetic Systems could legally trade SLI shares. These days any acquisition is greeted favorably.
Great earnings. Rev. up a lot. They have not given optimistic guidance for 3rd qtr or raised yearly guidance very much. Also, new orders for 6 months only up 3%. Still, this is a cheap stock, and they absorbed restructuring costs in 1st qtr. Note 4 mil. purchase of Dynetic System assets under subsequent events in 10-Q
I was looking at INTT last night. Did they explain in CC why eps guidance for 3rd qtr suggests a drop vs last year 3rd qtr?
Me neither. I might infer someone new was accumulating a large stake, but given current ownership (Gabelli, Steel Partners) that seems unlikely. I hope it isn't momentum traders. No new Form 4's.
The U.S. Food and Drug Administration isn't required to hold public hearings to evaluate the health risks of widespread use of antibiotics in animal feed, a federal appeals court ruled Thursday.
The decision by the 2nd U.S. Circuit Court of Appeals reversed a ruling in 2012 by a district court that sided with several health and consumer organizations that sued the FDA after the agency decided against holding the hearings.
The health groups want the FDA to withdraw approval of using penicillin and tetracycline in animal feed to make cattle and other livestock grow faster. They say the practice has been linked to an increase to human resistance to antibiotics, while industry groups argue the issue needs more study.
This doesn't seem consistent with remarks at CC. Wheat acreage will be at 3 year low, and canola plantings are affected.
see bloomberg news
Haven't you notice stock price jump recently thanks to the potential financial engineering? Even more recently, they are interviewing investment advisors.